.png)
Metagenomics Market By Product, Technology and Application - Global Industry Analysis And Forecast To 2027
Published On : October 2018 Pages : 180 Category: Biotechnology Report Code : HC101445
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Metagenomics Market By Product (Sequencing & Data Analytics Services, Kits & Reagents and Other Products), Technology (Function Driven and Sequencing Driven) and Application (Human Health, Environmental and Other Applications) - Global Industry Analysis And Forecast To 2027
Industry Outlook
Metagenomics is the research of the hereditary material recovered straightforwardly from the samples of environment. The expansive field can likewise be known to as eco-genomics, community genomics or the environmental genomics. While the conventional microbiology and the sequencing of microbial genome and the genomics depend upon the developed clonal cultures, initially the sequencing of environmental gene cloned particular genes so as to develop a profile of decent variety in the natural sample. This research uncovered that by far most of microbial biodiversity had been overlooked by the methods based on cultivation. Recent research utilize either PCR coordinated sequencing or "shotgun" to get to a great extent unprejudiced examples of all the genes from every one of the individuals from the inspected communities. Therefore, the Metagenomics Market is anticipated to expand and has tremendous scope during the forecast period. The global Metagenomics Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
Based on Product the market is segmented into Sequencing & Data Analytics Services, Kits & Reagents and Other Products. The Kits & Reagents section is leading the market owing to factors like; more numbers of launches & rise in the utilization for the workflows related to library preparations from the research labs, latest technology used for sequencing, improvement in the compatibility, etc.
Based on Technology the market is segmented into Function Driven and Sequencing Driven. The Sequencing Driven section is leading the market due to more implementation of this technology, more adoption due to increase in the solutions related to the novel bioinformatics, etc.
Based on Application the market is segmented into Human Health, Environmental and Other Applications. The section environmental is leading the marketing due to wide range of adoption, increasing utilization in the agriculture sector, rising use in treatment of wastewater, oil spills cleanup & leak of gasoline, and some other factors.
Regional Insights
The North American region is leading the global Metagenomics Market owing to factor, many organizations dealing in biotechnology present out of which more of them involved in metagenomics.
Metagenomics Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- ELITechGroup
- Illumina Inc.
- QIAGEN
- Promega Corporation
- Novogene Corporation
- Danaher
- Oxford Gene Technology Inc.
- TAKARA BIO INC.
- Thermo Fisher Scientific Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Metagenomics Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o Sequencing & Data Analytics Services
o Kits & Reagents
o Other Products
o Metagenomics Market, By Technology, Estimates and Forecast, 2017-2027 ($Million)
o Function Driven
o Sequencing Driven
o Metagenomics Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Human Health
o Environmental
o Other Applications
o Metagenomics Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Metagenomics Market, By Country
o U.S. Metagenomics Market
o Canada Metagenomics Market
o Mexico Metagenomics Market
o Europe
§ Europe Metagenomics Market, By Country
o Germany Metagenomics Market
o UK Metagenomics Market
o France Metagenomics Market
o Russia Metagenomics Market
o Italy Metagenomics Market
o Rest of Europe Metagenomics Market
o Asia-Pacific
§ Asia-Pacific Metagenomics Market, By Country
o China Metagenomics Market
o Japan Metagenomics Market
o South Korea Metagenomics Market
o India Metagenomics Market
o Southeast Asia Metagenomics Market
o Rest of Asia-Pacific Metagenomics Market
o South America
§ South America Metagenomics Market, By Country
o Brazil Metagenomics Market
o Argentina Metagenomics Market
o Columbia Metagenomics Market
o Rest of South America Metagenomics Market
o Middle East and Africa
§ Middle East and Africa Metagenomics Market, By Country
o Saudi Arabia Metagenomics Market
o UAE Metagenomics Market
o Egypt Metagenomics Market
o Nigeria Metagenomics Market
o South Africa Metagenomics Market
o Rest of MEA Metagenomics Market
Table of Contents
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Metagenomics Market, By Product
5.1. Introduction
5.2. Global Metagenomics Revenue and Market Share by Product (2017-2027)
5.2.1. Global Metagenomics Revenue and Revenue Share by Product (2017-2027)
5.3. Sequencing & Data Analytics Services
5.3.1. Global Sequencing & Data Analytics Services Revenue and Growth Rate (2017-2027)
5.4. Kits & Reagents
5.4.1. Global Kits & Reagents Revenue and Growth Rate (2017-2027)
5.5. Other Products
5.5.1. Global Other Products Revenue and Growth Rate (2017-2027)
6. Metagenomics Market, By Technology
6.1. Introduction
6.2. Global Metagenomics Revenue and Market Share by Technology (2017-2027)
6.2.1. Global Metagenomics Revenue and Revenue Share by Technology (2017-2027)
6.3. Function Driven
6.3.1. Global Function Driven Revenue and Growth Rate (2017-2027)
6.4. Sequencing Driven
6.4.1. Global Sequencing Driven Revenue and Growth Rate (2017-2027)
7. Metagenomics Market, By Application
7.1. Introduction
7.2. Global Metagenomics Revenue and Market Share by Application (2017-2027)
7.2.1. Global Metagenomics Revenue and Revenue Share by Application (2017-2027)
7.3. Human Health
7.3.1. Global Human Health Revenue and Growth Rate (2017-2027)
7.4. Environmental
7.4.1. Global Environmental Revenue and Growth Rate (2017-2027)
7.5. Other Applications
7.5.1. Global Other Applications Revenue and Growth Rate (2017-2027)
8. Metagenomics Market, By Region
8.1. Introduction
8.2. Global Metagenomics Revenue and Market Share by Regions
8.2.1. Global Metagenomics Revenue by Regions (2017-2027)
8.3. North America Metagenomics by Countries
8.3.1. North America Metagenomics Revenue and Growth Rate (2017-2027)
8.3.2. North America Metagenomics Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Metagenomics by Countries
8.4.1. Europe Metagenomics Revenue and Growth Rate (2017-2027)
8.4.2. Europe Metagenomics Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Metagenomics by Countries
8.5.1. Asia-Pacific Metagenomics Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Metagenomics Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Metagenomics by Countries
8.6.1. South America Metagenomics Revenue and Growth Rate (2017-2027)
8.6.2. South America Metagenomics Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Metagenomics by Countries
8.7.1. Middle East and Africa Metagenomics Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Metagenomics Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. ELITechGroup
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Revenue and Market Share
9.2. Illumina Inc.
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Revenue and Market Share
9.3. QIAGEN
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Revenue and Market Share
9.4. Promega Corporation
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Revenue and Market Share
9.5. Novogene Corporation
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Revenue and Market Share
9.6. Danaher
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Revenue and Market Share
9.7. Oxford Gene Technology Inc.
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Revenue and Market Share
9.8. TAKARA BIO INC.
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Revenue and Market Share
9.9. Thermo Fisher Scientific Inc.
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Revenue and Market Share
10. Global Metagenomics Market Competition, by Manufacturer
10.1. Global Metagenomics Revenue and Market Share by Manufacturer (2017-2017)
10.2. Global Metagenomics Price By Region (2017-2017)
10.3. Top 5 Metagenomics Manufacturer Market Share
10.4. Market Competition Trend
11. Metagenomics Market Forecast (2017-2027)
11.1. Global Metagenomics Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Metagenomics Market Forecast by Regions (2017-2027)
11.2.1. North America Metagenomics Market Forecast (2017-2027)
11.2.1.1. United States Metagenomics Market Forecast (2017-2027)
11.2.1.2. Canada Metagenomics Market Forecast (2017-2027)
11.2.1.3. Mexico Metagenomics Market Forecast (2017-2027)
11.2.2. Europe Metagenomics Market Forecast (2017-2027)
11.2.2.1. Germany Metagenomics Market Forecast (2017-2027)
11.2.2.2. France Metagenomics Market Forecast (2017-2027)
11.2.2.3. UK Metagenomics Market Forecast (2017-2027)
11.2.2.4. Russia Metagenomics Market Forecast (2017-2027)
11.2.2.5. Italy Metagenomics Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Metagenomics Market Forecast (2017-2027)
11.2.3. Asia-Pacific Metagenomics Market Forecast (2017-2027)
11.2.3.1. China Metagenomics Market Forecast (2017-2027)
11.2.3.2. Japan Metagenomics Market Forecast (2017-2027)
11.2.3.3. Korea Metagenomics Market Forecast (2017-2027)
11.2.3.4. India Metagenomics Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Metagenomics Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Metagenomics Market Forecast (2017-2027)
11.2.4. South America Metagenomics Market Forecast (2017-2027)
11.2.4.1. Brazil Metagenomics Market Forecast (2017-2027)
11.2.4.2. Argentina Metagenomics Market Forecast (2017-2027)
11.2.4.3. Columbia Metagenomics Market Forecast (2017-2027)
11.2.4.4. Rest of South America Metagenomics Market Forecast (2017-2027)
11.2.5. Middle East and Africa Metagenomics Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Metagenomics Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Metagenomics Market Forecast (2017-2027)
11.2.5.3. Egypt Metagenomics Market Forecast (2017-2027)
11.2.5.4. Nigeria Metagenomics Market Forecast (2017-2027)
11.2.5.5. South Africa Metagenomics Market Forecast (2017-2027)
11.2.5.6. Turkey Metagenomics Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Metagenomics Market Forecast (2017-2027)
11.3. Metagenomics Market Forecast by Product (2017-2027)
11.3.1. Metagenomics Forecast by Product (2017-2027)
11.3.2. Metagenomics Market Share Forecast by Product (2017-2027)
11.4. Metagenomics Market Forecast by Technology (2017-2027)
11.4.1. Metagenomics Forecast by Technology (2017-2027)
11.4.2. Metagenomics Market Share Forecast by Technology (2017-2027)
11.5. Metagenomics Market Forecast by Application (2017-2027)
11.5.1. Metagenomics Forecast by Application (2017-2027)
11.5.2. Metagenomics Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Metagenomics Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Metagenomics Revenue and Revenue Share by Product (2017-2018)
Figure Global Sequencing & Data Analytics Services Revenue and Growth Rate (2017-2018)
Figure Global Kits & Reagents Revenue and Growth Rate (2017-2018)
Figure Global Other Products Revenue and Growth Rate (2017-2018)
Table Global Metagenomics Revenue and Revenue Share by Technology (2017-2018)
Figure Global Function Driven Revenue and Growth Rate (2017-2018)
Figure Global Sequencing Driven Revenue and Growth Rate (2017-2018)
Table Global Metagenomics Revenue and Revenue Share by Application (2017-2018)
Figure Global Human Health Revenue and Growth Rate (2017-2018)
Figure Global Environmental Revenue and Growth Rate (2017-2018)
Figure Global Other Applications Revenue and Growth Rate (2017-2018)
Table Global Metagenomics Revenue by Regions (2017-2018)
Figure North America Metagenomics Growth Rate (2017-2018)
Figure North America Metagenomics Revenue and Growth Rate (2017-2018)
Figure North America Metagenomics by Countries (2017-2018)
Figure North America Metagenomics Revenue (Million USD) by Countries (2017-2018)
Figure United States Metagenomics Growth Rate (2017-2018)
Figure United States Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Metagenomics Growth Rate (2017-2018)
Figure Canada Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Metagenomics Growth Rate (2017-2018)
Figure Mexico Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Metagenomics Growth Rate (2017-2018)
Figure Europe Metagenomics Revenue and Growth Rate (2017-2018)
Figure Europe Metagenomics by Countries (2017-2018)
Figure Europe Metagenomics Revenue (Million USD) by Countries (2017-2018)
Figure Germany Metagenomics Growth Rate (2017-2018)
Figure Germany Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Metagenomics Growth Rate (2017-2018)
Figure France Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Metagenomics Growth Rate (2017-2018)
Figure UK Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Metagenomics Growth Rate (2017-2018)
Figure Russia Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Metagenomics Growth Rate (2017-2018)
Figure Italy Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Metagenomics Growth Rate (2017-2018)
Figure Rest of Europe Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Metagenomics Growth Rate (2017-2018)
Figure Asia-Pacific Metagenomics Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Metagenomics by Countries (2017-2018)
Figure Asia-Pacific Metagenomics Revenue (Million USD) by Countries (2017-2018)
Figure China Metagenomics Growth Rate (2017-2018)
Figure China Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Metagenomics Growth Rate (2017-2018)
Figure Japan Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Metagenomics Growth Rate (2017-2018)
Figure Korea Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Metagenomics Growth Rate (2017-2018)
Figure India Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Metagenomics Growth Rate (2017-2018)
Figure Southeast Asia Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Metagenomics Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Metagenomics Growth Rate (2017-2018)
Figure South America Metagenomics Revenue and Growth Rate (2017-2018)
Figure South America Metagenomics by Countries (2017-2018)
Figure South America Metagenomics Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Metagenomics Growth Rate (2017-2018)
Figure Brazil Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Metagenomics Growth Rate (2017-2018)
Figure Argentina Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Metagenomics Growth Rate (2017-2018)
Figure Columbia Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Metagenomics Growth Rate (2017-2018)
Figure Rest of South America Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Metagenomics Growth Rate (2017-2018)
Figure Middle East and Africa Metagenomics Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Metagenomics by Countries (2017-2018)
Figure Middle East and Africa Metagenomics Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Metagenomics Growth Rate (2017-2018)
Figure Saudi Arabia Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Metagenomics Growth Rate (2017-2018)
Figure United Arab Emirates Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Metagenomics Growth Rate (2017-2018)
Figure Egypt Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Metagenomics Growth Rate (2017-2018)
Figure Nigeria Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Metagenomics Growth Rate (2017-2018)
Figure South Africa Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Metagenomics Growth Rate (2017-2018)
Figure Turkey Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Metagenomics Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Metagenomics Revenue (Millions USD) and Growth Rate (2017-2018)
Table ELITechGroup Metagenomics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Illumina Inc. Metagenomics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table QIAGEN Metagenomics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Promega Corporation Metagenomics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novogene Corporation Metagenomics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Danaher Metagenomics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Oxford Gene Technology Inc. Metagenomics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table TAKARA BIO INC. Metagenomics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Thermo Fisher Scientific Inc. Metagenomics Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Metagenomics Market Share by Manufacturer
Figure Global Metagenomics Revenue and Market Share by Manufacturer
Table Global Metagenomics Price by Region (2017-2017)
Figure Top 5 Metagenomics Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Metagenomics Revenue (Millions USD) and Growth Rate (2018-2025)
Table Metagenomics Market Forecast by Regions (2018-2025)
Figure North America Metagenomics Market Forecast (2018-2025)
Figure United States Metagenomics Market Forecast (2018-2025)
Figure Canada Metagenomics Market Forecast (2018-2025)
Figure Mexico Metagenomics Market Forecast (2018-2025)
Figure Europe Metagenomics Market Forecast (2018-2025)
Figure Germany Metagenomics Market Forecast (2018-2025)
Figure France Metagenomics Market Forecast (2018-2025)
Figure UK Metagenomics Market Forecast (2018-2025)
Figure Russia Metagenomics Market Forecast (2018-2025)
Figure Italy Metagenomics Market Forecast (2018-2025)
Figure Rest of Europe Metagenomics Market Forecast (2018-2025)
Figure Asia-Pacific Metagenomics Market Forecast (2018-2025)
Figure China Metagenomics Market Forecast (2018-2025)
Figure Japan Metagenomics Market Forecast (2018-2025)
Figure Korea Metagenomics Market Forecast (2018-2025)
Figure India Metagenomics Market Forecast (2018-2025)
Figure Southeast Asia Metagenomics Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Metagenomics Market Forecast (2018-2025)
Figure South America Metagenomics Market Forecast (2018-2025)
Figure Brazil Metagenomics Market Forecast (2018-2025)
Figure Argentina Metagenomics Market Forecast (2018-2025)
Figure Columbia Metagenomics Market Forecast (2018-2025)
Figure Rest of South America Metagenomics Market Forecast (2018-2025)
Figure Middle East and Africa Metagenomics Market Forecast (2018-2025)
Figure Saudi Arabia Metagenomics Market Forecast (2018-2025)
Figure United Arab Emirates Metagenomics Market Forecast (2018-2025)
Figure Egypt Metagenomics Market Forecast (2018-2025)
Figure Nigeria Metagenomics Market Forecast (2018-2025)
Figure South Africa Metagenomics Market Forecast (2018-2025)
Figure Turkey Metagenomics Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Metagenomics Market Forecast (2018-2025)
Figure Global Metagenomics Forecast by Product (2018-2025)
Figure Global Metagenomics Market Share Forecast by Product (2018-2025)
Figure Global Metagenomics Forecast by Product (2018-2025)
Figure Global Metagenomics Forecast by Technology (2018-2025)
Figure Global Metagenomics Market Share Forecast by Technology (2018-2025)
Figure Global Metagenomics Forecast by Technology (2018-2025)
Figure Global Metagenomics Forecast by Application (2018-2025)
Figure Global Metagenomics Market Share Forecast by Application (2018-2025)
Figure Global Metagenomics Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|